We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




X-Ray Dark-Field Radiography Offers Clues into Lung Disorders

By MedImaging International staff writers
Posted on 12 Jun 2014
Scientists, for the first time, tested X-ray dark-field radiography on a living organism to diagnose lung disease. This enables highly detailed images of the lung to be generated. This approach has the potential to detect diseases such as pulmonary emphysema at an earlier stage, than it is currently available.

Traditional radiographic procedures generate images based on the absorption of X-rays as they pass through the tissue. The newly developed technique of X-ray dark-field radiography uses new technology to track wave alteration during tissue transmission to generate higher resolution images.

With the help of this new technique, investigators from Helmholtz Zentrum Munchen (HMGU; Germany), working in cooperation with the Ludwig-Maximilians-Universitat Hospital (Munich, Germany) and the Technische Universitat Munchen (TUM; Germany), in particular Dr. Ali Onder Yildirim and Prof. Oliver Eickelberg, from the Comprehensive Pneumology Center (CPC; Munich, Germany), which is one of the centers of the German Center for Lung Research (DZL), achieved detailed images of soft tissue.

The study was conducted in cooperation with the Cluster of Excellence Munich-Center for Advanced Photonics (MAP). The scientists employed a small-animal scanner developed by Prof. Franz Pfeifer at the TUM to assess X-ray dark-field radiography on a living organism. For their investigations, they evaluated and compared images of the lung. “With X-ray dark-field radiography, structural changes in the lung tissue are visible at an early stage,” said Dr. Yildirim from the CPC/HMGU.

“Early detection of changes in the lung tissue will improve the diagnosis of lung diseases,” explained Dr. Felix Meinel, from the Institute of Clinical Radiology at the University Hospital Munich. The clinical application, in particular the diagnosis of lung diseases such as pulmonary emphysema or pulmonary fibrosis, will now be evaluated in further research.

Lung disorders are among the leading causes of death worldwide. Lifestyle, genetics, and environmental factors all play a role in their development. The work of the Helmholtz Zentrum München, the German Research Center for Environmental Health, focuses on the most common diseases with the goal of devising new strategies to their diagnosis, treatment, and prevention.

The study’s findings were published May 21, 2014, in the Investigative Radiology journal. Earlier findings were published November 13, 2013, in the journal Nature Scientific Reports.

Related Links:

Helmholtz Zentrum Munchen
Ludwig-Maximilians-Universitat Hospital
Technische Universitat Munchen


Adjustable Mobile Barrier
M-458
X-Ray Generator
Advantage Plus Generators
Digital X-Ray Detector Panel
Acuity G4
Medical Radiographic X-Ray Machine
TR30N HF

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.